SERP1 and angina unstable: Of central interest to the translational potential of virus-derived immune-modulating biologics, Serp-1 was examined in patients with unstable coronary syndromes, unstable angina and small heart attacks with coronary stent implant, in the first human clinical trial of a viral protein.